Cargando…
Drug resistance and combating drug resistance in cancer
Cancer is the second leading cause of death in the US. Current major treatments for cancer management include surgery, cytotoxic chemotherapy, targeted therapy, radiation therapy, endocrine therapy and immunotherapy. Despite the endeavors and achievements made in treating cancers during the past dec...
Autores principales: | Wang, Xuan, Zhang, Haiyun, Chen, Xiaozhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315569/ https://www.ncbi.nlm.nih.gov/pubmed/34322663 http://dx.doi.org/10.20517/cdr.2019.10 |
Ejemplares similares
-
Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer
por: Zhang, Haiyun, et al.
Publicado: (2021) -
Evolution-Informed Strategies for Combating Drug Resistance in Cancer
por: Lin-Rahardja, Kristi, et al.
Publicado: (2023) -
Insights on the Role of Polyphenols in Combating Cancer Drug Resistance
por: Farhan, Mohd
Publicado: (2023) -
Extracellular ATP, as an energy and phosphorylating molecule, induces different types of drug resistances in cancer cells through ATP internalization and intracellular ATP level increase
por: Wang, Xuan, et al.
Publicado: (2017) -
Combating and overcoming drug resistance in cancer
por: Price, Douglas K.
Publicado: (2014)